Signature Gene Expression Profiles Discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-Treated Mycobacterium tuberculosis

Genomic technologies have the potential to greatly increase the efficiency of the drug development process. As part of our tuberculosis drug discovery program, we used DNA microarray technology to profile drug-induced effects in Mycobacterium tuberculosis. Expression profiles of M. tuberculosis trea...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Betts, Joanna C., McLaren, Alistair, Lennon, Mark G., Kelly, Fiona M., Lukey, Pauline T., Blakemore, Steve J., Duncan, Ken
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2003
Soggetti:
Mechanisms of Action: Physiological Effects
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC182614/
https://ncbi.nlm.nih.gov/pubmed/12936993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.9.2903-2913.2003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi